119 related articles for article (PubMed ID: 28535456)
1. Effectiveness of treatment for opioid use disorder: A national, five-year, prospective, observational study in England.
Eastwood B; Strang J; Marsden J
Drug Alcohol Depend; 2017 Jul; 176():139-147. PubMed ID: 28535456
[TBL] [Abstract][Full Text] [Related]
2. Continuous opioid substitution treatment over five years: Heroin use trajectories and outcomes.
Eastwood B; Strang J; Marsden J
Drug Alcohol Depend; 2018 Jul; 188():200-208. PubMed ID: 29778774
[TBL] [Abstract][Full Text] [Related]
3. Correlates of specialty substance use treatment among adults with opioid use disorders.
Romo E; Ulbricht CM; Clark RE; Lapane KL
Addict Behav; 2018 Nov; 86():96-103. PubMed ID: 29551551
[TBL] [Abstract][Full Text] [Related]
4. Change in alcohol and other drug use during five years of continuous opioid substitution treatment.
Eastwood B; Strang J; Marsden J
Drug Alcohol Depend; 2019 Jan; 194():438-446. PubMed ID: 30502545
[TBL] [Abstract][Full Text] [Related]
5. Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England.
Marsden J; Stillwell G; Jones H; Cooper A; Eastwood B; Farrell M; Lowden T; Maddalena N; Metcalfe C; Shaw J; Hickman M
Addiction; 2017 Aug; 112(8):1408-1418. PubMed ID: 28160345
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of community treatments for heroin and crack cocaine addiction in England: a prospective, in-treatment cohort study.
Marsden J; Eastwood B; Bradbury C; Dale-Perera A; Farrell M; Hammond P; Knight J; Randhawa K; Wright C;
Lancet; 2009 Oct; 374(9697):1262-70. PubMed ID: 19800681
[TBL] [Abstract][Full Text] [Related]
7. Long-term retention in Office Based Opioid Treatment with buprenorphine.
Weinstein ZM; Kim HW; Cheng DM; Quinn E; Hui D; Labelle CT; Drainoni ML; Bachman SS; Samet JH
J Subst Abuse Treat; 2017 Mar; 74():65-70. PubMed ID: 28132702
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with buprenorphine versus methadone use in pregnancy.
Krans EE; Bogen D; Richardson G; Park SY; Dunn SL; Day N
Subst Abus; 2016; 37(4):550-557. PubMed ID: 26914546
[TBL] [Abstract][Full Text] [Related]
9. Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies.
Betts KS; Chan G; McIlwraith F; Dietze P; Whittaker E; Burns L; Alati R
Addiction; 2016 Jul; 111(7):1214-23. PubMed ID: 26857811
[TBL] [Abstract][Full Text] [Related]
10. Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program.
Rowe C; Santos GM; Vittinghoff E; Wheeler E; Davidson P; Coffin PO
Addiction; 2015 Aug; 110(8):1301-10. PubMed ID: 25917125
[TBL] [Abstract][Full Text] [Related]
11. Predictors of heroin abstinence in opiate substitution therapy in heroin-only users and dual users of heroin and crack.
Heidebrecht F; MacLeod MB; Dawkins L
Addict Behav; 2018 Feb; 77():210-216. PubMed ID: 29065377
[TBL] [Abstract][Full Text] [Related]
12. Very early disengagement and subsequent re-engagement in primary care Office Based Opioid Treatment (OBOT) with buprenorphine.
Hui D; Weinstein ZM; Cheng DM; Quinn E; Kim H; Labelle C; Samet JH
J Subst Abuse Treat; 2017 Aug; 79():12-19. PubMed ID: 28673522
[TBL] [Abstract][Full Text] [Related]
13. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).
Metrebian N; Groshkova T; Hellier J; Charles V; Martin A; Forzisi L; Lintzeris N; Zador D; Williams H; Carnwath T; Mayet S; Strang J
Addiction; 2015 Mar; 110(3):479-90. PubMed ID: 25251885
[TBL] [Abstract][Full Text] [Related]
14. The SOMATICS collaborative: Introduction to a National Institute on Drug Abuse cooperative study of pharmacotherapy for opioid treatment in criminal justice settings.
Chandler RK; Finger MS; Farabee D; Schwartz RP; Condon T; Dunlap LJ; Zarkin GA; McCollister K; McDonald RD; Laska E; Bennett D; Kelly SM; Hillhouse M; Mitchell SG; O'Grady KE; Lee JD
Contemp Clin Trials; 2016 May; 48():166-72. PubMed ID: 27180088
[TBL] [Abstract][Full Text] [Related]
15. Evidence of validity and reliability of the Opiate Dosage Adequacy Scale (ODAS) in a sample of heroin addicted patients in buprenorphine/naloxone maintenance treatment.
González-Saiz F; Lozano Rojas O; Trujols J; Alcaraz S; Siñol N; Pérez de Los Cobos J;
Drug Alcohol Depend; 2018 Feb; 183():127-133. PubMed ID: 29247974
[TBL] [Abstract][Full Text] [Related]
16. Six-Year Outcome of Opioid Maintenance Treatment in Heroin-Dependent Patients: Results from a Naturalistic Study in a Nationally Representative Sample.
Soyka M; Strehle J; Rehm J; Bühringer G; Wittchen HU
Eur Addict Res; 2017; 23(2):97-105. PubMed ID: 28376505
[TBL] [Abstract][Full Text] [Related]
17. The costs of crime during and after publicly funded treatment for opioid use disorders: a population-level study for the state of California.
Krebs E; Urada D; Evans E; Huang D; Hser YI; Nosyk B
Addiction; 2017 May; 112(5):838-851. PubMed ID: 27981691
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study.
Weiss RD; Potter JS; Griffin ML; Provost SE; Fitzmaurice GM; McDermott KA; Srisarajivakul EN; Dodd DR; Dreifuss JA; McHugh RK; Carroll KM
Drug Alcohol Depend; 2015 May; 150():112-9. PubMed ID: 25818060
[TBL] [Abstract][Full Text] [Related]
19. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
Reimer J; Verthein U; Karow A; Schäfer I; Naber D; Haasen C
Addiction; 2011 Sep; 106(9):1647-55. PubMed ID: 21489005
[TBL] [Abstract][Full Text] [Related]
20. Abstinence orientation and treatment practice: an analysis of German settings providing opioid maintenance therapy.
Trautmann S; Wittchen HU
Subst Use Misuse; 2012 Jan; 47(1):22-30. PubMed ID: 22060728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
